Remedo Clinitech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 02-07-2024
- Paid Up Capital ₹ 1.51 M
as on 02-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 752.85%
(FY 2021)
- Profit 0.13%
(FY 2021)
- Ebitda 56.38%
(FY 2021)
- Net Worth -408.62%
(FY 2021)
- Total Assets 6.81%
(FY 2021)
About Remedo Clinitech
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.51 M, as per Ministry of Corporate Affairs (MCA) records.
Harsh Bansal, Ruchir Mehra, Richeek Arya, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC282838
- Company No.
282838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Remedo Clinitech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruchir Mehra  | Director | 24-Jun-2016 | Current |
| Harsh Bansal | Director | 24-Jun-2016 | Current |
| Richeek Arya | Whole-Time Director | 22-Mar-2017 | Current |
| Pradeep Mehra | Director | 25-Sep-2019 | Current |
Financial Performance and Corporate Structure Insights of Remedo Clinitech.
Remedo Clinitech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 752.85% increase. The company also saw a slight improvement in profitability, with a 0.13% increase in profit. The company's net worth observed a substantial decline by a decrease of 408.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Remedo Clinitech?
In 2020, Remedo Clinitech had a promoter holding of 91.08% and a public holding of 8.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Remedo Clinitech?
Remedo Clinitech has a workforce of 59 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Remedo Clinitech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remedo Clinitech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
